Covid-19 Data Analyses in Brazil
NCT06652451 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 361000
Last updated 2025-09-18
Summary
This descriptive study aims to describe the Brazilian scenario of patients hospitalized due to COVID-19 and to analyze the impact of COVID-19 on the Brazilian public health system. Data will be extracted from the largest secondary database of the Brazilian public health system, DATASUS ("Departamento de Informática do Sistema Único de Saúde"), responsible for collecting, processing, analyzing and disseminating health information and statistics in the country. The analysis, performed only on patients hospitalized during the hospitalization episode, will also evaluate the impact of vaccination against COVID-19 on the immunocompromised population compared to the general population.
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-11-12
- Primary Completion
- 2024-11-29
- Completion
- 2024-11-29
Countries
- Brazil
Study Locations
More Related Trials
-
Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-Cov-2 Virus (COVID-19)
NCT04322123 ·Status: COMPLETED ·Phase: PHASE3
-
Add on to Azythromycine, Phytomedicine and/or Antimalarial Drug vs Hydroxychloroquine in Uncomplicated COVID-19 Patients
NCT04502342 ·Status: UNKNOWN ·Phase: PHASE2
-
Assessment of Efficacy and Safety of HCQ and Antibiotics Administrated to Patients COVID19(+)
NCT04351919 ·Status: WITHDRAWN ·Phase: PHASE4
-
Worldwide Trends on COVID-19 Research After the Declaration of COVID-19 Pandemic
NCT04460547 ·Status: UNKNOWN
-
Chloroquine Diphosphate for the Treatment of Severe Acute Respiratory Syndrome Secondary to SARS-CoV2
NCT04323527 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection
NCT04481633 ·Status: COMPLETED ·Phase: NA
-
A Phase Ib Induced Malaria Infection Study With the Combination of OZ439 and DSM265
NCT02389348 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Dynamics of Subclinical Malaria: Preliminary Study
NCT03483571 ·Status: COMPLETED
-
Plasmodium Vivax Efficacy Trial in Cruzeiro do Sul, Acre, Brazil
NCT02043652 ·Status: COMPLETED ·Phase: NA
-
Asymptomatic COVID-19 Infection Among Healthcare Workers
NCT04354792 ·Status: COMPLETED
-
Efficacy of 3 Regimens of Chloroquine and Primaquine for Treatment of P. Vivax Malaria, Cruzeiro do Sul, Acre, Brazil
NCT03610399 ·Status: COMPLETED ·Phase: NA
-
Efficacay of Chloroquine or Hydroxychloroquine in COVID-19 Treatment
NCT04353336 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effectiveness of OZ439 Against Early Plasmodium Falciparum Blood Stage Infection in Healthy Volunteers
NCT02453581 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19
NCT04802382 ·Status: UNKNOWN ·Phase: PHASE3
-
Prevention With Chloroquine in Health Personnel Exposed to Infection With Coronavirus Disease 2019 (COVID-19) (TS-COVID)
NCT04627467 ·Status: COMPLETED ·Phase: PHASE2
-
Chloroquine as Antiviral Treatment in Coronavirus Infection 2020
NCT04331600 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Safety and Efficacy of OT-101+Artemisinin in Hospitalized COVID-19 Subjects
NCT04801017 ·Status: UNKNOWN ·Phase: PHASE2
-
HOPE: A Trial of Hydroxichloroquine Plus Azithromycin in High Risk COVID-19
NCT04575558 ·Status: WITHDRAWN ·Phase: PHASE2
-
The Malaria Heart Disease Study
NCT04445103 ·Status: TERMINATED
-
Clinical Validation of Novel Malaria Diagnostic Tools for POC Point-of-Care Testing
NCT06225700 ·Status: COMPLETED
-
Absolute BA and OZ439 PK Effect of Different OZ439 Dose Volumes and Cobicistat Co-administration Study
NCT04069221 ·Status: COMPLETED ·Phase: PHASE1
-
PRophylaxis of Exposed COVID-19 Individuals With Mild Symptoms Using choloroquinE Compounds
NCT04351191 ·Status: TERMINATED ·Phase: PHASE4
-
Efficacy and Safety of Hydroxychloroquine and Azithromycin for Patients With Moderate to Severe COVID-19
NCT04329572 ·Status: SUSPENDED ·Phase: EARLY_PHASE1
-
Chloroquine Phosphate Prophylactic Use in Health Personnel Exposed to COVID-19 Patients
NCT04443270 ·Status: UNKNOWN ·Phase: PHASE1
-
Pyronaridine in Healthy Adult Participants Infected With Blood Stage Malaria
NCT05287893 ·Status: COMPLETED ·Phase: PHASE1